IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
58 hedge funds and large institutions have $23.7M invested in IVERIC bio, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 11 closing their positions.
5% more capital invested
Capital invested by funds: $22.6M → $23.7M (+$1.13M)
8% less funds holding
Funds holding: 63 → 58 (-5)
15% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 20
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$2.8M |
| 2 |
Renaissance Technologies
New York
|
+$522K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$401K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$118K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$112K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$2.57M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.44M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$616K |
| 4 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
-$460K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$168K |
ISEE Hedge Fund Activity: Q1 2019 in Review
58 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q1 2019, worth a combined $23.7M — up 5% from $22.6M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ISEE and 6 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 17 added.
The largest buyer was Tamarack Advisers, adding an estimated $2.8M. The largest seller was D.E. Shaw & Co, cutting an estimated $2.57M.
- 58 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q1 2019, down from 63 in Q4 2018.
- Funds reported $23.7M of IVERIC bio, Inc. Common Stock stock for Q1 2019, up 5% quarter-over-quarter.
- 6 funds opened new IVERIC bio, Inc. Common Stock positions in Q1 2019 and 11 closed out, a net change of -5 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q1 2019 was Tamarack Advisers, an estimated $2.8M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q1 2019 was D.E. Shaw & Co, an estimated $2.57M sold.
Based on aggregated 13F filings for Q1 2019.